CompletedNot Applicable

Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI

Spain662 participantsStarted 2008-10

Plain-language summary

Premature luteinization in patients undergoing IUI can occur in up to 24% of cycles. These patients, according to recent data, have a lower pregnancy rate than controls. The possibility to avoid premature luteinization with GnRH antagonist may restore the chances of achieving a pregnancy in these women.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * previous failed IUI cycle with premature luteinization Exclusion Criteria: * 39 years or older * not eligible for IUI (patent tubes, \> 3 million capacitated spermatozoa) * 4 previous IUI cycles

What they're measuring

Pregnancy rate

Timeframe: 2 weeks after intervention

Trial details

NCT IDNCT00780858

SponsorIVI Madrid

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2010-12

View on ClinicalTrials.gov More Infertility trials